Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.21 | 0.7 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |